As of 2024, only about 13 states cover GLP-1s for obesity under Medicaid
Overall, this is one of the places where we clearly need more data, but if you are hoping to get pregnant (especially if you are diagnosed with PMOS), this is worth discussing with your doctor
While anecdotal reports suggest GLP-1 drugs may reduce alcohol consumption, a Novo Nordisk spokesperson said a phase 2 trial will be studying semaglutide the active ingredient in Wegovy and Ozempic and related compounds for their effects on alcohol-related liver disease, with drinking habits monitored as a secondary outcome
These include: the type and severity of the condition youre using Vyvanse to treat other medical conditions you may have how well your kidneys work other medications you may take Typically, your doctor will start you on a low dosage
After the shortage ended, routine copycat compounding is no longer broadly permitted